Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation

被引:14
作者
Del-Rey, Manuel J.
Manzanares, Javier
Bosque, Alberto
Aguilo, Juan I.
Gomez-Rial, Jose
Roldan, Ernesto
Serrano, Antonio
Anel, Alberto
Paz-Artal, Estela
Allende, Luis M. [1 ]
机构
[1] Univ Madrid, Hosp 12 Octubre, Serv Inmunol, Madrid, Spain
[2] Univ Madrid, Hosp 12 Octubre, Secc Gastroenterol Pediat, Madrid, Spain
[3] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50009 Zaragoza, Spain
[4] Hosp Ramon y Cajal, Serv Inmunol, E-28034 Madrid, Spain
关键词
ALPS; apoptosis; Fas; primary immunodeficiency;
D O I
10.1016/j.imbio.2006.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder characterized by chronic lymphoproliferation, autoimmune manifestations and expansion of TCRY alpha beta(+)CD4(-)CD8(-) lymphocytes. The main pathogenic factor is a defective Fas-mediated apoptosis generally caused by mutations in the Fas gene. This report describes a new heterozygous Fas gene mutation in a boy with clinical and immunological features of ALPS. In vitro, T-cell blasts from the patient are completely resistant to the effects on the anti-Fas cytotoxic mAb CH-11, they also have a higher proliferation rate than T cells from healthy donors, while PHA-induced AICD is normal. The location of the mutation (I246S) found in the intracytoplasmic death domain, and the conservation of that residue in four different species from human suggest that 1246 is an essential amino acid for Fas function. The patient has inherited the mutation from his father who also shows defective Fas-mediated apoptosis but the clinical and immunological manifestations are much less severe. These results provide evidence that the penetrance of genetic defects in Fas is variable and that other factors may influence the phenotype of the disease. (c) 2007 Elsevier GrnbH. All rights reserved.
引用
收藏
页码:73 / 83
页数:11
相关论文
共 38 条
[1]   Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia [J].
Aspinall, AI ;
Pinto, A ;
Auer, IA ;
Bridges, P ;
Luider, J ;
Dimnik, L ;
Patel, KD ;
Jorgenson, K ;
Woodman, RC .
BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (15) :227-238
[2]   Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL [J].
Bosque, A ;
Pardo, J ;
Martínez-Lorenzo, MJ ;
Lasierra, P ;
Larrad, L ;
Marzo, I ;
Naval, J ;
Anel, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (06) :1812-1821
[3]   Down-regulation of normal human T cell blast activation:: roles of APO2L/TRAIL, FasL, and c-FLIP, Bim, or Bcl-x isoform expression [J].
Bosque, A ;
Pardo, J ;
Martinez-Lorenzo, MJ ;
Iturralde, M ;
Marzo, I ;
Piñeiro, A ;
Alava, MA ;
Naval, J ;
Anel, A .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (04) :568-578
[4]   CHRONIC LYMPHADENOPATHY SIMULATING MALIGNANT LYMPHOMA [J].
CANALE, VC ;
SMITH, CH .
JOURNAL OF PEDIATRICS, 1967, 70 (06) :891-+
[5]   Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency [J].
Chun, HJ ;
Zheng, LX ;
Ahmad, M ;
Wang, J ;
Speirs, CK ;
Siegel, RM ;
Dale, MK ;
Puck, J ;
Davis, J ;
Hall, CG ;
Skoda-Smith, S ;
Atkinson, TP ;
Straus, SE ;
Lenardo, MJ .
NATURE, 2002, 419 (6905) :395-399
[6]   LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE [J].
COHEN, PL ;
EISENBERG, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :243-269
[7]   A homozygous Fas ligand gene mutation in a patient causes a new type of autoirnmune lymphoproliferative syndrome [J].
Del-Rey, Manuel ;
Ruiz-Contreras, Jesus ;
Bosque, Alberto ;
Calleja, Sara ;
Gomez-Rial, Jose ;
Roldan, Ernesto ;
Morales, Pablo ;
Serrano, Antonio ;
Anel, Alberto ;
Paz-Artal, Estela ;
Allende, Luis M. .
BLOOD, 2006, 108 (04) :1306-1312
[8]   Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation [J].
Dianzani, U ;
Bragardo, M ;
DiFranco, D ;
Alliaudi, C ;
Scagni, P ;
Buonfiglio, D ;
Redoglia, V ;
Bonissoni, S ;
Correra, A ;
Dianzani, I ;
Ramenghi, U .
BLOOD, 1997, 89 (08) :2871-2879
[9]   DOMINANT INTERFERING FAS GENE-MUTATIONS IMPAIR APOPTOSIS IN A HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME [J].
FISHER, GH ;
ROSENBERG, FJ ;
STRAUS, SE ;
DALE, JK ;
MIDDELTON, LA ;
LIN, AY ;
STROBER, W ;
LENARDO, MJ ;
PUCK, JM .
CELL, 1995, 81 (06) :935-946
[10]   Signal transduction - FasL binds preassembled Fas [J].
Golstein, P .
SCIENCE, 2000, 288 (5475) :2328-2329